Yayınlanmış 1 Ocak 2017
| Sürüm v1
Dergi makalesi
Açık
Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer
Oluşturanlar
- 1. Hacettepe Univ, Fac Med, Dept Med Biochem, Ankara, Turkey
- 2. Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
- 3. Hacettepe Univ, Fac Sci, Dept Chem, Ankara, Turkey
Açıklama
Objective: Immunotherapy with intravesical Bacillus Calmette-Guerin (BCG) application is a gold standard treatment for high risk non-muscle invasive bladder cancer (NMIBC), despite its local and systemic side effects. We aimed to develop less toxic and more powerful therapeutic agents for the treatment of bladder cancer than live strain.
Dosyalar
10-4274-uob-905.pdf
Dosyalar
(684.3 kB)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:9ee20076cf9bc2d697f350d2c286b2c0
|
684.3 kB | Ön İzleme İndir |